$ALT (+1,4 %) is now performing again after the last trial report and crash.

Of course, there is a lot of risk at this early stage.

Let's see how the FDA sees it later on.

Current developments against:

* Obesity and its associated diseases

* MASH (Metabolic Dysfunction-Associated Steatohepatitis)

* Alcohol use disorder (AUD)

* Alcohol-Associated Liver Disease (ALD)

Earnings next week (11.11 - 15.11)

$SHOP (+1,25 %)

$SOUN

$MARA (+2,08 %)

$BABA (-1,99 %)

$CAVA

$SPOT (+0,13 %)

$AMAT (+5,85 %)

$DIS (+0,3 %)

$PLUG (+6,46 %)

$HD (+0,18 %)

$MNDY (+1,01 %)

$OXY (+0,6 %)

$RKLB (+2,45 %)

$BSEM

$ZETA (+2,98 %)

$SE (+0,79 %)

$RKT

$CSCO (+0,04 %)

$ASTS (+3,16 %)

$WULF (+3,01 %)

$ONON (+1,48 %)

$OKLO

$HUT (+2,79 %)

$NVAX (+1,23 %)

$HTZ (+2,65 %)

$LUNR

$CART

$TALN

$BITF (+11,49 %)

$GRAB (+1,4 %)

$JD (-1,84 %)

$LAZR

$ALT (+1,4 %)

$CRON (+0,37 %)

$ICL

$NICE

$CYBR (-0,05 %)

$BXSL (-0,03 %)

$DESP

$ARMK (+0,43 %)

$TSN (+0,08 %)

$RUM

$PGY

$TGI

$AAP (+0,41 %)

$AXSM (+0,37 %)

$AZN (-0,76 %)

$BILI (-3,59 %)

$LINC (+0,86 %)

$LQDA (+0,56 %)

$ALT (+1,4 %) I hope things are looking up😂

$ALT (+1,4 %) What do you think of the share?

The share is very exciting and after the drop I am now hoping for a nice return of 20%-30%